Christine Bunt is the founder of Verseau Therapeutics. Verseau Therapeutics has raised $50M in total funding.
Christine Bunt is the Chief Executive of Verseau Therapeutics Inc., an immunotherapy startup focused on developing treatments for cancer patients. The company aims to broaden the effectiveness of immunotherapy by enabling more patients to benefit from immune-targeted drugs.
Full founder directory · Investor directory · Company funding database · Fundraising library